Development and validation of reverse phase high performance liquid chromatographic method for determination of Tirofiban in serum

Darkovska-Serafimovska, Marija and Janevik-Ivanovska, Emilija and Arsova-Sarafinovska, Zorica and Djorgoski, Icko and Ugresic, Nenad (2014) Development and validation of reverse phase high performance liquid chromatographic method for determination of Tirofiban in serum. International Journal of Pharmacy, 4 (4). pp. 115-120. ISSN 2249-1848

[thumbnail of DEVELOPMENT AND VALIDATION OF REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD FOR DETERMINATION OF TIROFIBAN IN SERUM.pdf]
Preview
Text
DEVELOPMENT AND VALIDATION OF REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD FOR DETERMINATION OF TIROFIBAN IN SERUM.pdf

Download (247kB) | Preview

Abstract

А specific, sensitive and rapid RP-HPLC method has been developed for the determination of Tirofiban in serum. The chromatographic separation was realized using reverse phase LiChrospher® 100 RP-18 column (4.0 mm × 250 mm, 5 μm) and mobile phase consisting the mixture of 0.1 M KH2PO4 (pH 5.2, adjusted with 1.0 N sodium hydroxide solution) and acetonitrile, with the ratio of 70:30% (v/v) and flow rate of 1.0 ml/min. The detection was carried out at 274 nm. The response was linear over the range of 0.03 – 0.18 mgmL-1 in mobile phase and serum samples. The limit of detection (LOD) for Tirofiban was 1.84, 13.8 and 14.6 μg mL-1 in methanol, spiked rat serum and spiked human serum, respectively. The described method can be quickly and routinely applied, without any interference from endogenous substances, for therapeutic monitoring of levels of Tirofiban in the serum samples.

Item Type: Article
Subjects: Medical and Health Sciences > Basic medicine
Medical and Health Sciences > Health sciences
Divisions: Faculty of Medical Science
Depositing User: Emilija Janevik
Date Deposited: 26 Nov 2014 10:20
Last Modified: 26 Nov 2014 10:21
URI: https://eprints.ugd.edu.mk/id/eprint/11461

Actions (login required)

View Item View Item